
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
The American Journal of Managed Care
about 25 years ago
A Pharmacy-Based Approach to Cholesterol Managementabout 25 years ago
Can Health Systems Heal Themselves?about 25 years ago
Chronic Pelvic Pain in Women





